As of 12:04pm ET
| +0.07 / +1.18%|
The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +275.00% increase from the last price of 6.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.